Apyx Medical Corporation (NASDAQ:APYX) is expected to report third quarter earnings results, after market close, on Monday 11th November 2019.
Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.18 per share.
Looking ahead, the full year loss are expected at $ 0.65 per share on the revenues of $ 26.97 million.
The Company Outlook
Full Year 2019 topline are forecasted in a range of$ 25.5 million ~ $ 26.5 million
Historical Earnings Performance
3Q18 results topped wall street estimates by 90.00 percent, the report represented loss of $ 0.01 per share from the revenues of $ 3.67 million, analysts expected loss of $ 0.1 per share
4Q18 results met street expectation, the report depicted loss of $ 0.1 per share from the topline of $ 5.93 million, analysts forecasted loss of $ 0.1 per share
1Q19 results surpassed wall street view by 22.22 percent, the report outlined loss of $ 0.14 per share from the revenues of $ 5.82 million, analysts predicted loss of $ 0.18 per share
2Q19 results topped street expectation by 27.78 percent, the report interpreted loss of $ 0.13 per share from the topline of $ 6.57 million, analysts anticipated loss of $ 0.18 per share